Cell Cycle/Checkpoint(细胞周期/检查点)

Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0. read more
Products for Cell Cycle/Checkpoint
- ATM/ATR(29)
- Aurora Kinase(57)
- Cdc42(4)
- Cdc7(3)
- Chk(13)
- c-Myc(27)
- CRM1(8)
- Cyclin-Dependent Kinases(69)
- E1 enzyme(1)
- G-quadruplex(12)
- Haspin(5)
- HMTase(1)
- Kinesin(27)
- Ksp(4)
- Microtubule/Tubulin(248)
- Mps1(13)
- Mitotic(7)
- RAD51(13)
- ROCK(69)
- Rho(13)
- PERK(11)
- PLK(42)
- PTEN(6)
- Wee1(8)
- PAK(24)
- Arp2/3 Complex(8)
- Dynamin(14)
- ECM & Adhesion Molecules(52)
- Cytoskeleton & Motor Proteins(63)
- Endomembrane System & Vesicular Trafficking(35)
- G1(48)
- Genotoxic Stress(22)
- G2/M(35)
- G2/S(16)
- Inositol Phosphates(67)
- Proteolysis(179)
- Cellular Chaperones(14)
- Cyclin G-associated Kinase (GAK)(1)
- MARK(3)
- NEKs(1)
- Cat.No. 产品名称 Information
-
GC33006
CCT020312
CCT020312是一种选择性蛋白激酶R样内质网激酶(PERK)通路激动剂。
-
GC11310
CCT129202
2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺,CCT-129202, CCT 129202
An Aurora kinase inhibitor -
GC14566
CCT137690
甲磺酸阿贝西尼
An inhibitor of Aurora kinases and FLT3 -
GC18053
CCT241533
(3R,4S)-4-[[2-(5-氟-2-羟基苯基)-6,7-二甲氧基-4-喹唑啉基]氨基]-ALPHA,ALPHA-二甲基-3-吡咯烷甲醇,CCT 241533;CCT-241533
A selective Chk2 inhibitor -
GC17105
CCT241533 hydrochloride
CCT241533盐酸盐,CCT-241533 hydrochloride;CCT 241533 hydrochloride
A selective Chk2 inhibitor -
GC19092
CCT241736
A dual inhibitor of Aurora kinases and FLT3
-
GC14772
CCT244747
3-[(1R)-2-(二甲基氨基)-1-甲基乙氧基]-5-[[4-甲氧基-5-(1-甲基-1H-吡唑-4-基)-2-吡啶基]氨基]-2-吡嗪甲腈
A potent Chk1 inhibitor -
GC33213
CCT251455
CCT251455是有效和选择性的有丝分裂激酶单极纺锤体1(MPS1)抑制剂,IC50值为3nM。
-
GC18051
CCT251545 analogue, Compound 51
Potent, Selective, orally bioavailable CDK 8/19 Inhibitor
-
GC48982
CD532
An inhibitor of Aurora A kinase activity and the Aurora A-N-Myc protein-protein interaction
-
GC62189
CD532 hydrochloride
An inhibitor of Aurora A kinase activity and the Aurora A-N-Myc protein-protein interaction
-
GC12425
CDK inhibitor II
CDK inhibitorII
CDK inhibitor II 是一种有效且特异性的 CDK9 抑制剂,IC50 <8 nM,取自参考文献 1,实施例 4。 -
GC43217
CDK/CRK Inhibitor
Cdk7 Inhibitor IV, Cyclin-dependent kinase 7 Inhibitor IV, Cyclin-dependent kinase/CDK-related kinase Inhibitor, RGB-286147
A CDK/CRK-specific kinase inhibitor -
GC14294
Cdk1/2 Inhibitor III
Cyclin-dependent kinase 1/2 Inhibitor III
A cell-permeable inhibitor of Cdk1 and Cdk2 -
GC43219
Cdk2 Inhibitor II
Cyclin-dependent kinase 2 Inhibitor II, SC-221409
Selective and potent inhibitor of Cdk2 -
GC11785
CDK4 inhibitor
瑞博西尼
An antiproliferative cyclin D1/Cdk4 inhibitor -
GC11564
Cdk4/6 Inhibitor IV
CINK4
A cell-permeable inhibitor of Cdk4/6 -
GC12871
CDK9 inhibitor
N-[5-[[6-[3-(1,3-二氧代异吲哚-2-基)苯基]嘧啶-4-基]氨基]-2-甲基苯基]甲烷磺酰胺
CDK9 inhibitor 是一种新型的选择性 CDK9 抑制剂,用于治疗 HIV 感染,对 CDK9/CycT1 的 IC50 为 39 nM,从参考化合物 87 中提取。 -
GC17359
CDK9 inhibitor 2
N2'-(反式-4-氨基环己基)-5'-氯-N6-[(3-氟苯基)甲基]-[2,4'-联吡啶]-2',6-二胺
CDK9 inhibitor 2 是一种特殊的细胞周期蛋白依赖性激酶 9 (CDK9) 抑制剂,提取自专利 WO/2012131594A1,化合物 CDKI(8),在 H929 多发性骨髓瘤 (MM) 细胞系中的 IC50 分别为 5 nM 和 7 nM(72 小时) ) 和 A2058 皮肤细胞系(72 小时)。 -
GC35651
Cenisertib
AS-703569; R-763
Cenisertib (AS-703569) 是一种多激酶抑制剂,可抑制 Aurora-kinase-A/B,ABL1,AKT,STAT5, FLT3 的活性。 Cenisertib 通过抑制肿瘤肥大细胞 (MC) 中几种不同分子靶标的活性抑制其生长。 Cenisertib 抑制异种移植模型中胰腺癌,乳腺癌,结肠癌,卵巢癌和肺癌以及白血病的肿瘤生长。 -
GC32688
Centrinone (LCR-263)
LCR-263
A Plk4 inhibitor -
GC32751
Centrinone-B (LCR-323)
LCR-323
Centrinone-B (LCR-323) (LCR-323) 是一种有效且高度选择性的 PLK4 抑制剂,Ki 为 0.59 nM。 -
GN10780
Cephalomannine
三尖杉宁碱
A taxane diterpenoid -
GC52489
Ceramide (hydroxy) (bovine spinal cord)
A sphingolipid
-
GC52485
Ceramide (non-hydroxy) (bovine spinal cord)
A sphingolipid
-
GC52486
Ceramide Phosphoethanolamine (bovine)
N-Acyl Ceramide Phosphoethanolamine (d18:1/acyl mixture), CPE, N-acyl-D-erythro-Sphingosylphosphorylethanolamine
A sphingolipid -
GC43229
Ceramide Phosphoethanolamines (bovine)
Ceramide phosphoethanolamine (CPE) is an analog of sphingomyelin that contains ethanolamine rather than choline as the head group.
-
GC47073
Ceramides (hydroxy)
A mixture of hydroxy fatty acid-containing ceramides
-
GC43230
Ceramides (non-hydroxy)
Ceramides are generated from sphingomyelin through activation of sphingomyelinases or through the de novo synthesis pathway, which requires the coordinated action of serine palmitoyl transferase and ceramide synthase.
-
GC35654
Ceratamine A
Ceratamine A 是从海绵 Pseudoceratina sp. 中分离出的一种抗有丝分裂杂环生物碱,能作为一种微管稳定剂。Ceratamine A 对人类癌细胞系具有细胞毒性。
-
GC60688
Cereblon modulator 1
CC-90009
A modulator of cereblon -
GC47074
Cerebroside C
脑苷脂C
A fungal metabolite -
GC11905
Cevipabulin
5-氯-6-[2,6-二氟-4-[3-(甲基氨基)丙氧基]苯基]-N-((1S)-2,2,2-三氟-1-甲基乙基)-[1,2,4]三唑并[1,5-A]嘧啶-7-胺,TTI-237
An activator of microtubule polymerization -
GC35659
Cevipabulin fumarate
TTI-237 fumarate
An activator of microtubule polymerization -
GC13606
CFI-400945
orally available, selective inhibitor of polo-like kinase 4 (PLK4)
-
GC35660
CFI-400945 free base
CFI-400945 free base 是一种高效,选择性的,可口服的 PLK4 抑制剂,Ki 和 IC50 值分别为 0.26 nM 和 2.8 nM。
-
GC14526
CGK733
ATM/ATR Kinase Inhibitor
An anticancer compound -
GC50175
CGP 74514 dihydrochloride
Potent cdk1 inhibitor
-
GC48992
CGP 77675 (hydrate)
An inhibitor of Src family kinases
-
GC14650
CGP60474
3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇,CGP-60474;CGP 60474
A CDK inhibitor -
GC62145
Chiauranib
CS2164
Chiauranib (CS2164) selectively inhibits multiple kinase targets aurora B kinase (AURKB), colony-stimulating factor 1 receptor (CSF1R), and vascular endothelial growth factor receptor (VEGFR)/platelet-derived growth factor receptor (PDGFR)/c-Kit , thereby inhibiting the rapid proliferation of tumor cells, enhancing the antitumor immunity, and inhibiting tumor angiogenesis, to achieve the anti-tumor efficacy. -
GC15739
CHIR-124
4-[((3S)-1-氮杂双环[2,2,2]辛-3-基)氨基]-3-(1H-苯并咪唑-2-基)-6-氯喹啉-2(1H)-酮
A selective Chk1 inhibitor -
GC43239
Chk2 Inhibitor
SC-203885
A Chk2 inhibitor -
GC47078
Chlorambucil-d8
CB-1348-d8; WR-139013-d8
苯丁酸氮芥 (CB-1348-d8) 是氘标记的苯丁酸氮芥。苯丁酸氮芥 (CB-1348) 是一种具有口服活性的抗肿瘤剂,是一种属于氮芥类的双功能烷化剂。苯丁酸氮芥可用于淋巴细胞白血病、卵巢癌和乳腺癌以及霍奇金病的研究。 -
GC47079
Chloramine-T (hydrate)
氯氨T
A common reagent -
GC43250
Cho-Arg (trifluoroacetate salt)
A steroid-based cationic lipid
-
GC50145
CHR 6494 trifluoroacetate
A selective Haspin protein kinase inhibitor
-
GC17254
CHR-6494
3-(1H-吲唑-5-基)-N-丙基咪唑并[1,2-B]哒嗪-6-胺,CHR 6494;CHR6494
A selective Haspin protein kinase inhibitor -
GC16097
Chroman 1
(3S)-N-[2-[2-(二甲基氨基)乙氧基]-4-(1H-吡唑-4-基)苯基]-3,4-二氢-6-甲氧基-2H-1-苯并吡喃-3-甲酰胺,ROCK-II inhibitor
A ROCK2 inhibitor -
GC49334
Chroman 1 (hydrochloride hydrate)
(S)-Chroman 1
A ROCK2 inhibitor